Innovation

March 30, 2026 Alnylam Named One of Fast Company's Most Innovative Companies for 2026 RNAi therapeutics pioneer has been recognized by Fast Company as one of the most innovative companies for the 3rd time and ranks #3 in the "Medicines and Therapeutics" category. Read More ›
March 26, 2026 Alnylam Awarded 2026 Scientific Impact Award by MassBio Alnylam was recognized by Mass Bio for its pioneering work in RNA interference and the development of RNAi therapeutics as an innovative new class of medicines. Read More ›
September 9, 2025 Five in A Row! Alnylam Named a 2025 Best Workplace for Innovators by Fast Company We're proud to be named a Best Workplace for Innovators by Fast Company for the 5th year in a row. Read More ›
July 11, 2023 Alnylam Named a Best Workplace for Innovators for the 3rd Year in a Row by Fast Company Alnylam has been named a Fast Company Best Workplace for Innovators for 2023, our 3rd year in a row. Read More ›
March 2, 2023 Alnylam Named One of Fast Company's Most Innovative Companies for 2023 Alnylam is one of Fast Company's Most Innovative Companies for 2023, and is ranked #5 in the Medicines and Therapeutics category. Read More ›
August 2, 2022 Alnylam Named #1 Best Workplace for Innovators by Fast Company Alnylam has been named the #1 Best Workplace for Innovators by Fast Company for 2022. Read More ›
May 9, 2022 Building a Collaborative Framework for Facilitating Patient Access to Innovative Therapies Alnylam worked with leading European economists and other healthcare experts to develop what we call the Value-Based Negotiation Framework (VBNF) to help... Read More ›